澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Argent BioPharma Limited

0.031

0.000

成交量：1,057

成交額：33

市值：361.49萬

市盈率：-0.35

高：0.031

開：0.031

低：0.031

收：0.031

52周最高：0.110

52周最低：0.030

股本：1.17億

流通股本：2,770.41萬

量比：0.02

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-0.089

每股收益(LYR):-0.089

淨資產收益率：--

總資產收益率：-246.78%

市淨率：-0.38

市盈率(LYR):-0.35

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Splash Beverage Group 獲C/M Capital Partners 100萬美元戰略投資用於Cannepil項目開發

Splash Beverage Group發行550萬美元優先股；作為許可對價，Argent BioPharma的500萬美元債務獲豁免

Argent BioPharma Limited 與皮膚健康研究所達成長期授權與供應協議

Argent BioPharma Limited簽署獨家全球協議授權Aquiol用於皮膚科化妝品應用

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/RGT.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RGT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","market":"AU","secType":"STK","nameCN":"Argent BioPharma Limited","latestPrice":0.031,"timestamp":1789711920000,"preClose":0.031,"halted":0,"volume":1057,"delay":0,"changeRate":0,"nameEN":"Argent BioPharma Limited","floatShares":27704074,"shares":116609584,"eps":-0.0889,"marketStatus":"休市中","change":0,"latestTime":"09-18 16:12:00 AEST","open":0.031,"high":0.031,"low":0.031,"amount":33,"amplitude":0,"askPrice":0.034,"askSize":477993,"bidPrice":0.031,"bidSize":30737,"shortable":3,"etf":0,"ttmEps":-0.0889,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789948800000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.031,"openAndCloseTimeList":[[1789689600000,1789711200000]],"volumeRatio":0.019368055295177065,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RGT.AU","preClose":0.031,"auctionPrice":0.031,"auctionVolume":209,"auction":3,"marketStatus":"盘后竞价","timestamp":1789538439814}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RGT.AU\",,,,,undefined,":{"symbol":"RGT.AU","floatShares":27704074,"roa":"-246.78%","roe":"--","lyrEps":-0.0889,"volumeRatio":0.019368055295177065,"shares":116609584,"dividePrice":0,"high":0.031,"amplitude":0,"preClose":0.031,"low":0.031,"week52Low":0.03,"pbRate":"-0.38","psRate":"22.43","week52High":0.11,"institutionHeld":0,"latestPrice":0.031,"committee":-0.879162,"eps":-0.0889,"divideRate":0,"volume":1057,"delay":0,"ttmEps":-0.0889,"open":0.031,"prevYearClose":0.07,"prevWeekClose":0.033,"prevMonthClose":0.033,"prevQuarterClose":0.036,"fiveDayClose":0.033,"twentyDayClose":0.038,"sixtyDayClose":0.037},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-09-23","symbol":"RGT.AU","reason":null,"defaultRemindTime":1727049600000,"announcedDate":"2024-08-15","type":"delisting","dateTimestamp":1727013600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGT.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1106861486","title":"Splash Beverage Group 獲C/M Capital Partners 100萬美元戰略投資 用於Cannepil項目開發","url":"https://stock-news.laohu8.com/highlight/detail?id=1106861486","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106861486?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 20:33","pubTimestamp":1783341227,"startTime":"0","endTime":"0","summary":"Splash Beverage Group Inc. 已成功获得来自C/M Capital Partners的100万美元战略投资。这笔资金将专项用于其Cannepil项目的开发工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RGT.AU","SBEV","BK4113","BK4169"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149601606","title":"Splash Beverage Group發行550萬美元優先股；作為許可對價，Argent BioPharma的500萬美元債務獲豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=1149601606","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149601606?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 20:33","pubTimestamp":1783341222,"startTime":"0","endTime":"0","summary":"Splash Beverage Group Inc. 宣布发行一笔价值550万美元的优先股。与此同时，该公司所欠Argent BioPharma Limited的500万美元债务，已作为一项许可对价被全额豁免。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBEV","BK4169","BK4113","BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175261776","title":"Argent BioPharma Limited 與皮膚健康研究所達成長期授權與供應協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1175261776","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175261776?lang=zh_tw&edition=fundamental","pubTime":"2026-05-25 07:08","pubTimestamp":1779664095,"startTime":"0","endTime":"0","summary":"Argent BioPharma Limited 已与皮肤健康研究所签署一项长期授权与供应协议。此举标志着该公司在拓展其生物医药产品应用领域方面迈出了重要一步，旨在通过专业机构的合作，深化其在皮肤健康市场的布局。该协议的达成预计将为双方带来持续的商业与研发协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RGT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107937347","title":"Argent BioPharma Limited簽署獨家全球協議 授權Aquiol用於皮膚科化妝品應用","url":"https://stock-news.laohu8.com/highlight/detail?id=1107937347","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107937347?lang=zh_tw&edition=fundamental","pubTime":"2026-05-25 07:08","pubTimestamp":1779664091,"startTime":"0","endTime":"0","summary":"Argent BioPharma Limited已达成一项独家授权协议，获得Aquiol技术在皮肤科及化妆品应用领域的全球独家使用权。该协议标志着公司在皮肤病学产品组合拓展方面取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RGT.AU\",params:#limit:6,delay:true,,,undefined,":[]}}